Drug Discovery for Parkinson’s
Sometimes, personal experience can fuel accelerated research and promise advanced cures. Eight years ago at the age of 49, Jonathan Silverstein received a grim diagnosis: Parkinson’s...
News
The latest news and updates about NYSCF and our collaborators
34 Results
Clear Filters
Allen Institute for Cell Science and New York Stem Cell Foundation Join Forces to Advance Inclusive Cellular Biology
Partnership combines advanced cellular tagging with ethnically diverse stem cell lines, addressing critical gaps in biomedical research Seattle, WA and New York, NY – September 4,...
Brain Disease Research Gets a New Backdrop: Space
If you picture where brain disease research takes place, you might conjure an image of a laboratory full of white-coated scientists tinkering with microscopes and pipettes....
For Brain Disease Research, Patients Lead the Way
“There are 55 million people worldwide living with Alzheimer’s or other dementias, 2.8 million living with multiple sclerosis, and 10 million with Parkinson’s,” shared NYSCF Vice...
Music, Mentorship, and Medicine: Highlights of the NYSCF Innovators Retreat
This May, we gathered once again in beautiful Montauk for the NYSCF Innovator Retreat, in the 13th installment of an annual meeting where the NYSCF –...
NYSCF Innovator Malin Parmar’s Investigational Cell Therapy for Parkinson’s Reaches First Patient In Clinical Trial
STEM-PD, a investigational cell therapy developed by NYSCF – Robertson Stem Cell Investigator Alumna Malin Parmar, PhD, of Lund University, reached its first patient last month...
The NYSCF Conference Returns in Person to Showcase Seminal Advances in Translational Stem Cell Research
On October 18th and 19th, we hosted the seventeenth annual NYSCF Conference at The Rockefeller University, convening in person again after two years of virtual meetings....
A NYSCF – Supported Cell Therapy for Parkinson’s Disease is Entering Clinical Trials
A major hallmark of Parkinson’s disease is the loss of dopamine-producing neurons in the brain, which in turn causes patients to lose motor control abilities. NYSCF...
Replacing the Brain’s Cleanup Machinery to Treat Neurological Disease
The Context: Microglia are resident immune cells of the brain that are constantly patrolling the central nervous system to eliminate dead or damaged cells. Defects in...
Experts Explore the Power of Artificial Intelligence in Brain Disease Research
How is artificial intelligence (AI) augmenting and improving disease research? A group representing several facets of the disease experience recently gathered to discuss how new research...
Artificial Intelligence and Robotics Uncover Hidden Signatures of Parkinson’s Disease
New York Stem Cell Foundation (NYSCF) Research Institute collaborates with Google Research to identify new cellular characteristics of disease in skin cells from Parkinson’s patients NEW...
What are Stem Cells, and How Can They Accelerate Better Treatments for Disease?
Alzheimer’s, Parkinson’s, multiple sclerosis, cancer: they’re all diseases that are, to this day, largely a mystery, and treatment options are scarce. But thanks to stem cells,...
Persisting Even When a Pandemic Delays a PhD: Meet Jenna Hall
When COVID-19 hit, Jenna Hall’s plans were completely upended. Set to embark on a PhD at the University of Melbourne in Australia, border closures meant an...
Showing Up For Science: Highlights of the NYSCF Gala
On October 5th, celebrities, scientists, and supporters ‘showed up for science’ at the The 2021 New York Stem Cell Foundation Gala. Hosted by CNN’s Chief Medical...
The Stem Cell Science You Won’t Want to Miss at The NYSCF Conference
Annually for the past 15 years, the NYSCF Conference has showcased the latest cutting-edge findings in translational stem cell research, gathering world-renowned multi-disciplinary speakers and 500+...
Defining Parkinson’s Triggers and Catalyzing New Therapies
Why do some people develop Parkinson’s disease (PD) while others do not? The answer involves a complex interplay between genetics, aging, and other factors. Stem cells...
A Clearer Window Into Disease: Meet the Opera Phenix Microscope
At the root of every major disease of our time is the simple question: what is going wrong with our cells? Once scientists know exactly how...
Valentina Fossati Explains Why We Sent Patient Cells to Space
Cover photo: Dr. Valentina Fossati (NYSCF) and Jason Stein (Aspen Neuroscience) prepare cells for launch. Photo credit: Space Tango Why send cells affected by multiple sclerosis...
Showing Up for Science: Celebrities and Stem Cells Take Center Stage at the NYSCF Gala
Hosted by CNN’s Chief Medical Correspondent Sanjay Gupta, MD, this year’s New York Stem Cell Foundation Research Institute Gala & Science Fair went virtual for the...
Consortium Including NYSCF Scientists Receives Grant Award to Study Parkinson’s Disease Risk Factors
A multi-institutional team of scientists led by Lorenz Studer, MD (Memorial Sloan Kettering Cancer Center) and including Gist Croft, PhD (The NYSCF Research Institute), NYSCF –...
NYSCF Scientists Create the ‘Stars’ of the Brain and Capture Their Rogue Behavior in Disease
Read the press release here. You may not have heard of astrocytes before, but your body is full of them: they make up more than...
When Astrocytes Attack: Stem Cell Model Shows Possible Mechanism Behind Neurodegeneration
Human stem-cell-derived astrocytes can be triggered to become toxic to neurons, opening the door for new understanding and treatment of neurodegenerative diseases. Featured image credit: Christina...
NYSCF Scientists Talk Space, Stem Cells, and their Pioneering Study of MS and PD
The International Space Station (ISS) houses more than astronauts: the football-field-sized spacecraft is also home to a large range of research projects carried out in the...
NYSCF Collaboration Sends Multiple Sclerosis and Parkinson’s Disease Brain Cells to Space
Brain cells derived from the stem cells of multiple sclerosis and Parkinson’s disease patients are on their way up to the International Space Station! This afternoon,...
First-in-kind Human 3-dimensional Models of Parkinson’s Disease and Progressive Multiple Sclerosis Launching to the International Space Station
First patient-derived, induced pluripotent stem cell disease-specific organoid models in microgravity to advance understanding of neurodegenerative disease LOUISVILLE, KY — (BUSINESS WIRE) — The National Stem...